Skip to main content
. 2020 Jun 22;77(9):1–11. doi: 10.1001/jamaneurol.2020.1840

Figure 4. Mean Score Changes From Baseline to Month 18 for the Secondary (Device 1) Cohort .

Figure 4.

The model used time as a categorical variable and included fixed effects for the treatment, the treatment-by-time interactions, baseline outcome, sex, age, baseline score on the Mini-Mental State Examination, and apolipoprotein E ε4 allele carriage status. The shaded region indicates the open-label phase. Error bars indicate 95% CIs.